Advertisement
Screener

Establishment Labs Holdings Inc. (ESTA) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price

2.7 / 5 stars · 42/79 Roast Me

Establishment Labs Holdings Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price

Establishment Labs Holdings Inc. (ESTA) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $30.91 per share for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-05-08

  • Establishment Labs Holdings Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2026-03-31 was $30.91, a 65.92% increase year-over-year.
  • Establishment Labs Holdings Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2025-03-31 was $18.63, a 30.22% decline year-over-year.
  • Establishment Labs Holdings Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2024-03-31 was $26.70, a 9.43% increase year-over-year.
  • Establishment Labs Holdings Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2023-03-31 was $24.40, a 63.10% increase year-over-year.
  • Establishment Labs Holdings Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $29.57, a 61.76% increase from fiscal 2024.
  • Establishment Labs Holdings Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $18.28, a 4.09% decline from fiscal 2023.
  • Establishment Labs Holdings Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $19.06, a 48.33% increase from fiscal 2022.
  • Establishment Labs Holdings Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $12.85, a 7.62% increase from fiscal 2021.
Period endShare-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month
2026-03-31$30.91
10-Q · filed 2026-05-08
2025-12-31$29.57
10-K · filed 2026-02-27
2025-09-30$23.45
10-Q · filed 2025-11-07
2025-06-30$22.93
10-Q · filed 2025-08-07
2025-03-31$18.63
10-Q · filed 2025-05-09
2024-12-31$18.28
10-K · filed 2025-02-28
2024-09-30$18.30
10-Q · filed 2024-11-12
2024-06-30$18.18
10-Q · filed 2024-08-07
2024-03-31$26.70
10-Q · filed 2024-05-09
2023-12-31$19.06
10-K · filed 2024-03-04
2023-09-30$23.21
10-Q · filed 2023-11-08
2023-06-30$22.62
10-Q · filed 2023-08-09
2023-03-31$24.40
10-Q · filed 2023-05-10
2022-12-31$12.85
10-K · filed 2023-03-01
2022-09-30$13.84
10-Q · filed 2022-11-09
2022-06-30$14.12
10-Q · filed 2022-08-09
2022-03-31$14.96
10-Q · filed 2022-05-10
2021-12-31$11.94
10-K · filed 2022-03-01
2021-09-30$12.41
10-Q · filed 2021-11-09
2021-06-30$12.60
10-Q · filed 2021-07-30
2021-03-31$11.54
10-Q · filed 2021-05-06
2020-12-31$8.70
10-K · filed 2021-03-15
2020-09-30$6.77
10-Q · filed 2020-11-09
2020-06-30$5.99
10-Q · filed 2020-08-07
2020-03-31$4.56
10-Q · filed 2020-05-08
2019-12-31$8.78
10-K · filed 2020-03-16
2019-09-30$5.23
10-Q · filed 2019-11-12
2019-06-30$6.22
10-Q · filed 2019-08-13
2019-03-31$14.13
10-Q · filed 2019-05-15
2018-12-31$4.87
10-K · filed 2019-03-20
2018-09-30$4.91
10-Q · filed 2018-11-13
2018-06-30$4.11
10-Q · filed 2018-09-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B
NutriBand Inc. (NTRB)United States$0.109B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
Safe Pro Group Inc. (SPAI)United States$0.090B
MYOMO, INC. (MYO)United States$0.065B-2.85